BioCryst, Scolr Pharma deal

DDD will use its Controlled Delivery Technology (CDT) to develop an oral formulation of BCRX's peramivir to treat seasonal and pandemic influenza. BCRX will own rights to the oral formulation of the neuraminidase inhibitor. ...